Drugnews|藥時事

HMDBIO

厚美德生物科技股份有限公司

6660 · Emerging Stock Board

HMDBIO focuses on blood glucose monitoring systems, test strips and diabetes care consumables, as of 2026-11-01.

Pipeline and products

No publicly disclosed new-drug pipeline.

Key events

Related Drugnews articles

No related articles in this language.